FT
Fortrea Holdings Inc. (FTRE)
NASDAQ·Healthcare·Biotechnology
$24.46
+2.62%
Mkt Cap $2.25B
Analyst Ratings
Buy
7
Hold
6
Sell
0
Price Target (36 analysts)
$20.50
Range $16.00 – $23.00
Implied Upside
-16.2%
Consensus $20.50 vs current $24.46
NASDAQ·Healthcare·Biotechnology
$24.46
+2.62%
Mkt Cap $2.25B
Buy
7
Hold
6
Sell
0
Price Target (36 analysts)
$20.50
Range $16.00 – $23.00
-16.2%
Consensus $20.50 vs current $24.46